Related Experiment Video

Updated: Feb 23, 2026

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.7K

Hyperuricemia is associated with progression of chronic kidney disease in patients with reduced functioning kidney

Isabel Galán1, Marian Goicoechea1, Borja Quiroga1

  • 1Hospital General Universitario Gregorio Marañón, Spain.

Nefrologia
|September 5, 2017
PubMed

Insights

Hyperuricemia, or high uric acid levels, independently predicts worsening kidney function in individuals with reduced renal mass. This finding highlights the importance of managing uric acid to preserve kidney health in this vulnerable population.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Cardiovascular Disease

Background:

  • Hyperuricemia is a known risk factor for chronic kidney disease (CKD) development and progression.
  • Previous studies suggest a link between elevated serum uric acid and CKD, but this has not been extensively studied in patients with reduced renal mass.

Purpose of the Study:

  • To investigate the association between hyperuricemia and kidney function decline in patients with reduced renal mass.
  • To identify predictors of kidney disease progression in this specific patient group.

Main Methods:

  • Retrospective study of 324 outpatients with reduced renal mass, followed for a median of 60 months.
  • Data collected included demographics, cardiovascular factors, medications, albuminuria, and serum uric acid levels.
  • Kidney function decline was assessed by the annual fall in estimated glomerular filtration rate (eGFR).

Main Results:

  • Hyperuricemia was more frequent in patients with faster kidney function decline.
  • Higher pulse pressure and albuminuria were also associated with kidney disease progression.
  • Adjusted Cox regression models identified hyperuricemia, pulse pressure, and albuminuria as independent predictors of kidney disease progression.

Conclusions:

  • Hyperuricemia is an independent predictor of kidney disease progression in patients with reduced functioning renal mass.
  • Managing uric acid levels may be crucial for preserving kidney function in this population.
Abstract

Keywords:
Disminución de la masa renalHiperuricemiaHyperuricemiaKidney disease progressionNefrectomíaNephrectomyProgresión de enfermedad renalReduced kidney mass

More Related Videos

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.8K
Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography03:19

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography

Published on: June 21, 2024

2.5K

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
832
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
514
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
760
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
261
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
268